Protein Expression Systems Market to reach Size of US$ 2.9 Billion during forecast period 2019-2026 | CAGR: 11.1%: Coherent Market Insights
Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
The Global Protein Expression Systems Market, By Expression System (Mammalian Expression Systems, Insect Expression Systems, Bacterial Expression Systems, Plant Expression Systems, Yeast Expression Systems, and Cell-Free Expression Systems), By Product Type (Competent Cells, Instruments, Reagents, and Others), By Application (Protein Therapeutics and Research Studies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 1.2 billion in 2017, and is projected to exhibit a CAGR of 11.1% during the forecast period (2018 – 2026).
The production of proteins in appropriate quantity and quality is an essential requirement of the biopharmaceutical and biotechnology industry. Therapeutic proteins provide important therapies for a variety of diseases such as anemia, diabetes, cancer, infectious diseases, and hemophilia. There is a growing demand for recombinant proteins for therapeutic applications. Common therapeutic proteins include antibodies, anticoagulants, hormones, FC fusion proteins, interleukins, and enzymes. Human proteins obtained through genetic engineering play a crucial role in therapeutic medicines.
Browse 25 Market Data Tables and 27 Figures spread through 164 Pages and in-depth TOC on Protein Expression Systems Market, By Expression System (Mammalian Expression Systems, Insect Expression Systems, Bacterial Expression Systems, Plant Expression Systems, Yeast Expression Systems, and Cell Free Expression Systems), By Product Type (Competent Cells, Instruments, Reagents, and Others), By Application (Protein Therapeutics, and Research Studies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Global Forecast to 2026
To know the latest trends and insights related to protein expression systems market press release, click the link below: https://www.coherentmarketinsights.com/press-release/protein-expression-systems-market-to-surpass-us-29-billion-by-2026-1227
Currently, most of all recombinant therapeutic proteins are produced in mammalian cells are capable of producing high-quality proteins similar to the naturally occurring ones. Furthermore, many approved recombinant therapeutic proteins are generated in E. coli due to its well-characterized genetics, rapid growth, and high-yield production. Pharmaceutical companies are progressively focusing on research using proteins to develop novel effective therapeutics. Advances in molecular control of gene expression are also expanding the opportunities for protein expression systems. The next generation expression systems are gaining traction as drug manufacturers are looking for cheaper ways to express new biologic drugs. For instance, on 6 December 2018, AMSBIO introduced ALiCE, a new high-yield cell-free protein expression system. ALiCE is a unique eukaryotic system, which yields an unprecedented 3 mg/ml of protein in batch mode.
Apply Promo Code “STAYHOME” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/2383
Key Takeaways of the Protein Expression Systems Market:
- The global protein expression systems market is expected to expand at a CAGR of 11.1% during the forecast period (2018–2026) owing to the increasing demand for protein therapeutics.
- Among expression system, the mammalian expression systems segment is expected to generate significant revenue in 2018. The major advantage to this system is that the antibody will be as close to native structure as possible, giving the highest possibility of proper binding activity.
- Major players operating in the global protein expression systems market are Agilent Technologies, Inc., Becton, Dickinson & Company, Lonza Group Ltd., GenScript Biotech Corporation, Bio-Rad Laboratories, Inc., Merck KGaA, QIAGEN N.V., Thermo Fisher Scientific Inc., Takara Bio Inc., Synthetic Genomics Inc., Lucigen Corporation, Promega Corporation, ARTES Biotechnology GmbH, ProteoGenix, Addgene Inc., Geneva Biotech, Profacgen, and Peak Proteins Ltd.
Other Related Reports:
Diabetes Devices and Drugs (Diagnosis, Monitoring, and Therapeutics) Market, By Category (Diagnosis and Monitoring (Blood Glucose Monitoring Devices, Other Testing Devices, Software Programs for Diabetes Monitoring, Artificial Pancreas), Therapeutics (Insulin, Insulin Delivery, Oral Hypoglycemic Agents, Cell Therapies)), By Disease Type (Type 2 Diabetes, Type 1 Diabetes), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) – Size, Share Outlook, and Opportunity Analysis, 2020 – 2027
Cell-free Protein Expression Market, By Product Type (E.coli Cell-free Protein Expression System, Rabbit Reticulocytes Cell-free Protein Expression System, Wheat Germ Cell-free Protein Expression System, Insect Cells Cell-free Protein Expression System, Mammalian Cell-free Protein Expression System, Labelling Tags, Vectors), By Application (Enzyme Engineering, Protein Labeling, Protein-Protein interaction, Protein Purification), By Expression Mode (Continuous flow Expression, Batch Expression), By End User (Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations, Academic/ Research Institutes ), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa ) – Size, Share Outlook, and Opportunity Analysis, 2019 – 2027
Reperfusion Treatment Market, by Treatment Type (Therapeutic Hypothermia, Cyclosporin, Stem Cell Therapy, Hydrogen Sulphide Treatment, and Others), By Injury Type (Heart Injury, Kidney Injury, Intestine Injury, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
- CDN Newswire